AI-powered trial analysis backed by current medical evidence.
Get StartedWe search ClinicalTrials.gov for active trials matching your condition and filter them for relevance.
Each trial is checked against recent medical literature for relevance to your condition.
You get ranked trials with plain-language explanations for each match.
| Without ClinTrialFinder | With ClinTrialFinder | |
|---|---|---|
| Results | Hundreds of trials to sift through | Top trials ranked by an overall suitability score |
| Context | Eligibility criteria only | Evidence summary for each trial |
| Language | Technical medical terms | Plain-language explanations |
Example search: Recurrent glioblastoma (IDH-wildtype, MGMT unmethylated), post Stupp protocol and bevacizumab/lomustine
Results: 207 trials analyzed, 108 top matches — ranked by confidence tier with evidence summaries, surfacing reasons, and risk flags
Score: 85/100 — Excellent Match · Strong Evidence
Why surfaced: Recurrent GBM eligible · Regorafenib with phase 2 evidence · Adaptive phase 2/3 platform
Evidence: Patient with progressive recurrent GBM fits trial; regorafenib arm offers modest survival benefit post-standard therapy; phase 2/3 adaptive design; manageable safety; trial recruiting.
Uses AI-based matching algorithms and current medical evidence from trusted sources.
Searches the official ClinicalTrials.gov database directly for your condition.
Developed by a data scientist with personal experience navigating clinical trials. Learn more
It searches ClinicalTrials.gov for any condition. Results quality depends on how many active trials exist for your disease.
ClinicalTrials.gov lists all trials. We rank them using AI-based eligibility scoring and evidence from recent medical literature, with plain-language explanations.
Built by a data scientist with personal experience navigating clinical trials.
Most searches complete within 2β5 minutes. You can leave the page and come back later β your results will be saved. If you provide your email, we'll notify you when results are ready.
June 2026 updates: a new way to browse trials by mechanism (10 drug-class hubs plus a catalog), 12 new drug pages, patient-focused ASCO 2026 coverage, a much faster wizard (the first step went from ~20 seconds to near-instant), and matching-accuracy fixes.
What's New: Browse Before You SearchMay 2026 updates: 10 trial landscape pages for browse-before-you-search, 8 new drug pages, one-click prefill from cancer page to wizard, a faster treatment-history step that leads with line of therapy, and four ASCO 2026 patient previews.